Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

US Patent 8648087 · Granted Feb 11, 2014

Estimated economic value: $7,569,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of nitrogen-phosphorus doped porous carbon for oxygen reduction electroca2025
Compounds, compositions and methods2025
Antiviral pyrazolopiridinone compounds2025
5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases2025
Imaging methods using deuterated compounds2025
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I r2024
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I r2024
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I r2024
10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazi2024
KRas G12D inhibitors2024
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections2024
Inhibiting agents for bruton's tyrosine kinase2024